Finance Watch: Platforms Are Great, But Investors Want To See Drug Candidates
VCs Say Start-Ups Need Long-Term Thinking, Near-Term Milestones
Private Company Edition: Panelists at Biocom’s Global Life Science Partnering Conference noted a shift in the types of early-stage drug developers getting venture funding going forward. In recent financings, Synthego closed a $200m series E and Plexium raised $102m.
